Provided by Tiger Trade Technology Pte. Ltd.

BAIYUNSHAN PH

13.430
-0.180-1.32%
Volume:1.86M
Turnover:25.01M
Market Cap:21.84B
PE:6.27
High:13.730
Open:13.730
Low:13.380
Close:13.610
52wk High:19.218
52wk Low:13.380
Shares:1.63B
HK Float Shares:219.90M
Volume Ratio:1.75
T/O Rate:0.85%
Dividend:0.86
Dividend Rate:6.43%
EPS(LYR):2.143
ROE:6.50%
ROA:2.09%
PB:0.48
PE(LYR):6.27
PS:0.24

Loading ...

Guangzhou Baiyunshan Pharmaceutical Sets 21 August 2026 Board Meeting to Review H1 2026 Unaudited Results

Bulletin Express
·
Aug 10

Baiyunshan Pharmaceutical Sets 28 Aug 2026 EGM to Approve New Director Pay Framework

Bulletin Express
·
Aug 07

Baiyunshan Pharma Schedules First Extraordinary General Meeting of 2026 to Approve Directors’ Remuneration Measures

Bulletin Express
·
Aug 07

Baiyunshan Pharmaceutical Subsidiary Receives Revised Drug Manufacturing License

MT Newswires Live
·
Aug 05

Baiyunshan Pharmaceutical Gets Macau Approval for Cefalexin Capsules

MT Newswires Live
·
Jul 21

Baiyunshan's Subsidiary Secures Macau Registration for Cefalexin Capsules

Stock News
·
Jul 20

Hong Kong Market Analysis: Capital Shifts from Tech to Biotech Amid Liquidity Drain and Sector Rotation

Stock News
·
Jul 10

Baiyunshan Reports Q1 2026 Revenue of 23.278 Billion Yuan, Up 3.58%

Deep News
·
Jul 10

Baiyunshan's Chen Jiehui Highlights Shift in Labor Demand: Decline in Traditional Workers, Surge in Innovative Talent

Deep News
·
Jun 23

Baiyunshan's Chen Jiehui: AI Technology Could Reduce New Drug Development Cycle to Five Years

Deep News
·
Jun 23

BAIYUNSHAN PH Subsidiary Obtains Drug Registration Certificate for Cefaclor Sustained-Release Tablets (II)

Stock News
·
Jun 10

Baiyunshan Pharma: May 2026 Monthly Return Shows Stable Share Capital, Full Public Float Compliance

Bulletin Express
·
Jun 02

Baiyunshan Pharmaceutical Gains China's Nod for Influenza Antiviral Suspension

MT Newswires Live
·
Jun 02

Key Corporate Updates from Hong Kong-Listed Firms: Drug Approvals, A-Share Plans, and May Sales Figures

Stock News
·
Jun 02

Baiyunshan Pharma Declares FY2025 Final Dividend of RMB 0.45 per Share; Payment Slated for 17 July 2026

Bulletin Express
·
May 29

BAIYUNSHAN PH to Distribute Final Dividend of HK$0.5162 per Share on July 17

Stock News
·
May 29

Guangzhou Baiyunshan Pharmaceutical Announces Updated Board Composition and Committee Structure

Bulletin Express
·
May 29

BAIYUNSHAN PH (00874) Appoints Chen Jiehui as Chairman and Legal Representative

Stock News
·
May 29

Baiyunshan's First Report Under Li Xiaojun Reveals Q4 Loss, Cash Shortfall Against Debt, and High Receivables

Deep News
·
May 26

BAIYUNSHAN PH (00874) Announces Completion of RMB 10 Billion Receivables Securitization by Guangzhou Pharmaceutical

Stock News
·
May 22